227 related articles for article (PubMed ID: 9428803)
1. Geldanamycin, an hsp90/GRP94-binding drug, induces increased transcription of endoplasmic reticulum (ER) chaperones via the ER stress pathway.
Lawson B; Brewer JW; Hendershot LM
J Cell Physiol; 1998 Feb; 174(2):170-8. PubMed ID: 9428803
[TBL] [Abstract][Full Text] [Related]
2. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.
Marcu MG; Doyle M; Bertolotti A; Ron D; Hendershot L; Neckers L
Mol Cell Biol; 2002 Dec; 22(24):8506-13. PubMed ID: 12446770
[TBL] [Abstract][Full Text] [Related]
4. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin, a heat shock protein 90-binding agent, disrupts Stat5 activation in IL-2-stimulated cells.
Xu W; Yu F; Yan M; Lu L; Zou W; Sun L; Zheng Z; Liu X
J Cell Physiol; 2004 Feb; 198(2):188-96. PubMed ID: 14603521
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.
Loo MA; Jensen TJ; Cui L; Hou Y; Chang XB; Riordan JR
EMBO J; 1998 Dec; 17(23):6879-87. PubMed ID: 9843494
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
[TBL] [Abstract][Full Text] [Related]
10. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.
Beliakoff J; Bagatell R; Paine-Murrieta G; Taylor CW; Lykkesfeldt AE; Whitesell L
Clin Cancer Res; 2003 Oct; 9(13):4961-71. PubMed ID: 14581371
[TBL] [Abstract][Full Text] [Related]
11. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
[TBL] [Abstract][Full Text] [Related]
12. p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.
Miyata Y; Yahara I
Oncogene; 2000 Mar; 19(11):1477-84. PubMed ID: 10723140
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Hsf1 activity by novobiocin and geldanamycin.
Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
Yun BG; Matts RL
Cell Signal; 2005 Dec; 17(12):1477-85. PubMed ID: 15935620
[TBL] [Abstract][Full Text] [Related]
15. Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.
Xu W; Mimnaugh EG; Kim JS; Trepel JB; Neckers LM
Cell Stress Chaperones; 2002 Jan; 7(1):91-6. PubMed ID: 11892991
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin and its anti-cancer activities.
Fukuyo Y; Hunt CR; Horikoshi N
Cancer Lett; 2010 Apr; 290(1):24-35. PubMed ID: 19850405
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade.
Mimnaugh EG; Xu W; Vos M; Yuan X; Neckers L
Mol Cancer Res; 2006 Sep; 4(9):667-81. PubMed ID: 16966435
[TBL] [Abstract][Full Text] [Related]
19. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates.
Hartson SD; Thulasiraman V; Huang W; Whitesell L; Matts RL
Biochemistry; 1999 Mar; 38(12):3837-49. PubMed ID: 10090774
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]